Publications (277) ANGEL LUIS GUERRERO PERAL publications

filter_list

2025

  1. Physical activity as a predictor of fremanezumab response in chronic migraine – the Phy-Fre-Mig study

    Journal of Headache and Pain, Vol. 26, Núm. 1

2024

  1. Acute and Preventive Treatment of COVID-19-Related Headache: A Series of 100 Patients

    Life, Vol. 14, Núm. 7

  2. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

  3. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  4. Evaluation of the burden of migraine on the partner's lifestyle

    Neurologia, Vol. 39, Núm. 9, pp. 810-819

  5. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

  6. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  7. Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza—Response

    European Journal of Neurology

  8. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology, Vol. 31, Núm. 8

  9. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

  10. Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study

    Pain and Therapy, Vol. 13, Núm. 3, pp. 557-576

  11. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data

    Current Pain and Headache Reports, Vol. 28, Núm. 12, pp. 1265-1272

  12. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Análisis de las alteraciones en la estructura neurofisiológica en la migraña

    CASEIB 2023. Libro de Actas del XLI Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Contribuyendo a la salud basada en valor

  2. Cefalea: concepto, diagnóstico, criterios de alerta y exploraciones complementarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 71, pp. 4143-4152

  3. Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

    Neurologia, Vol. 38, pp. S22-S30

  4. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses

    NeuroImage, Vol. 280

  5. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, pp. S37-S52

  6. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles

    Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239

  7. Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine

    Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334